Lesson plan
ProSavin
ProSavin is an experimental drug believed to be of use in the treatment of Parkinson's disease. It is administered to the striatum in the brain, inducing production of dopamine. It is manufactured by Oxford BioMedica. Results from a Phase I/II clinical trial were published in the Lancet and showed safety, but little efficacy. ProSavin was superseded by AXO-Lenti-PD (OXB-102), an optimized version of the drug.
Article summary
ProSavin is an experimental drug believed to be of use in the treatment of Parkinson's disease. It is administered to the striatum in the brain, inducing production of dopamine. It is manufactured by Oxford BioMedica. Results from a Phase I/II clinical trial were published in the Lancet and showed safety, but little efficacy. ProSavin was superseded by AXO-Lenti-PD (OXB-102), an optimized version of the drug.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.